Amprius Technologies (AMPX) vs Mesa Laboratories (MLAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Mesa Laboratories (MLAB) has outperformed Amprius Technologies (AMPX) over the past year, gaining 81.2% versus a loss of 42.9%. Amprius Technologies is the larger company by market cap ($846.1 million vs $719.0 million), about 1.2 times the size. Mesa Laboratories pays a dividend yielding 0.50%, while Amprius Technologies does not currently pay one.
Mesa Laboratories converts more of its revenue into profit, with a net margin of 2.7% versus -60.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMPX | MLAB |
|---|---|---|
| Share price | $5.77 | $127.93 |
| Market cap | $846.13M | $719.03M |
| 1-day change | -9.84% | -4.11% |
| YTD return | -26.87% | +62.97% |
| 1-year return | -42.93% | +81.20% |
| 5-year return | — | -59.10% |
| P/E ratio (TTM) | — | 110.28 |
| Forward P/E | — | 10.51 |
| EPS (TTM) | $-0.29 | $1.16 |
| Dividend yield | 0.00% | 0.50% |
| Annual dividend | $0.00 | $0.64 |
| Revenue (latest FY) | $73.01M | $249.13M |
| Revenue growth (YoY) | +202.11% | +3.38% |
| Net income (latest FY) | $-44.02M | $6.71M |
| Gross margin | 11.32% | 63.53% |
| Operating margin | -63.89% | 7.43% |
| Net margin | -60.30% | 2.69% |
| 52-week high | $24.23 | $144.35 |
| 52-week low | $5.72 | $70.19 |
| Distance from 52-week high | -76.18% | -11.38% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +232.76% | +17.25% |
| Average volume | 5.52M | 115.00K |
| Shares outstanding | 146.64M | 5.62M |
| Employees | 97 | 717 |
| Sector | Miscellaneous | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MLAB has outperformed AMPX by 124.1 percentage points over the past year.
- Mesa Laboratories is more profitable, keeping 2.7 cents of every revenue dollar as net income versus -60.3 cents for Amprius Technologies.
- Amprius Technologies grew revenue faster in its latest fiscal year (+202.11% vs +3.38%).
- The two companies sit in different sectors: Amprius Technologies in Miscellaneous and Mesa Laboratories in Industrials.
About Amprius Technologies
AMPX stock →Amprius Technologies, Inc. develops, manufactures, and markets lithium-ion batteries for mobility applications.
Miscellaneous · Industrial Machinery/Components · 97 employees
About Mesa Laboratories
MLAB stock →Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
Industrials · Industrial Machinery/Components · 717 employees
AMPX vs MLAB FAQ
Which is bigger, Amprius Technologies or Mesa Laboratories?
Amprius Technologies (AMPX) is larger, with a market capitalization of $846.13M compared with $719.03M for Mesa Laboratories (MLAB).
Which stock has performed better over the past year, AMPX or MLAB?
MLAB returned +81.20% over the past 12 months, compared with -42.93% for AMPX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Amprius Technologies or Mesa Laboratories?
Mesa Laboratories pays a dividend yielding 0.50%, while Amprius Technologies does not currently pay a regular dividend.
Are Amprius Technologies and Mesa Laboratories in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Miscellaneous sector.